Tim Doyle on CGT, selling Eucalyptus, and the future of healthcare
Eucalyptus co-founder Tim Doyle joins the Capital Brief newsroom for On The Call’s first ever guest episode. Doyle has been one of the most prominent voices in the startup sector’s response to Labor’s capital gains tax reforms, arguing the sector’s backlash against the reforms is rooted in self interest. This discussion revisits the debate and where the discourse on the tax reforms has landed. It also delves into the USD1.15 billion sale of Eucalyptus to Hims and Hers, as well as Doyle’s takes on the future of healthcare.
We discuss:
Tim Doyle's past gig buying political ads for Labor and his…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.